{
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "document": "CDC_Influenza_vaccines",
  "verification_stats": {
    "total_extracted": 2,
    "verified": 0,
    "rejected": 2,
    "verification_rate": 0.0
  },
  "verified_evidence": [],
  "rejected_evidence": [
    {
      "id": 1,
      "quote": "RIV4 (recombinant HA vaccine)",
      "reason": "does not support claim",
      "original_explanation": "This quote identifies RIV4 as a recombinant HA vaccine, which directly supports the claim that Flublok is produced using a recombinant technology platform."
    },
    {
      "id": 2,
      "quote": "HA = hemagglutinin; IIV4 = inactivated influenza vaccine, quadrivalent; ... RIV4 (recombinant HA vaccine)",
      "reason": "does not support claim",
      "original_explanation": "This quote defines RIV4 as a recombinant hemagglutinin vaccine, supporting the claim that Flublok is produced by expressing recombinant HA, which is a key part of the novel production platform described."
    }
  ],
  "model_used": "gpt-4.1"
}